Initial management of hydrocephalus associated with Chiari malformation Type I–syringomyelia complex via endoscopic third ventriculostomy: an outcome analysis

Hayhurst, Caroline; Osman-Farah, Jibril; Das, Kumar; Mallucci, Conor

doi:10.3171/jns/2008/108/6/1211

Cited by 98 publications

(43 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several authors [37,[75][76][77] have reported that hydrocephalus in Chiari patients can be treated with ETV and that the success rate of this treatment can be as high as 50%. The success rate in our series was 40%, which is within the range of rates that have been described in international series.…”

Section: Discussionmentioning

confidence: 99%

Endoscopic third ventriculostomy in the management of hydrocephalus: Outcome analysis of 168 consecutive procedures

Salvador

Oliveira

Pereira

et al. 2014

Clinical Neurology and Neurosurgery

View full text Add to dashboard Cite

a b s t r a c tBackground: Endoscopic third ventriculostomy (ETV) is the treatment of choice for obstructive hydrocephalus, but the outcome is still controversial in terms of age and aetiology. Methods: Between 1998 and 2011, 168 consecutive procedures were performed in 164 patients, primarily children (56% < 18 years of age and 35% < 2 years of age). The causes of obstructive hydrocephalus included tumoural pathology, Chiari malformation, congenital obstruction of the aqueduct, post-infectious and post-haemorrhagic membranes, and ventriculo-peritoneal shunt (VPS) malfunctions. Successful ETV was defined by the resolution of symptoms and the avoidance of a shunt. Results: ETV was successful in 75.6% of patients, but 19% of the patients required VPS in the first month after ETV, and 5.4% required a VPS more than one month after ETV. Four patients were ultimately submitted for second ETVs. In this series, no major permanent morbidity or mortality was observed. Conclusions: ETV is a safe procedure and an effective treatment for obstructive hydrocephalus even following the dysfunction of previous VPSs and in children younger than two years.

show abstract

Section: Discussionmentioning

confidence: 99%

Endoscopic third ventriculostomy in the management of hydrocephalus: Outcome analysis of 168 consecutive procedures

Salvador

Oliveira

Pereira

et al. 2014

Clinical Neurology and Neurosurgery

View full text Add to dashboard Cite

show abstract

“…Excellent outcomes and high long-term success rates ranging from 60 to 100% have been reported in both adult and pediatric series of OHC [2,3,4,5,6,7,9,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31]. Our 81.6% overall success rate is thus comparable to those of previous reports.…”

Section: Discussionmentioning

confidence: 99%

“…ETV is currently considered by many authors the treatment of choice for OHC [1,2,3,4,5,6,7,8,9,10]. Excellent outcomes and high long-term success rates ranging from 60 to 100% have been reported in both adult and pediatric series of OHC [2,3,4,5,6,7,9,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Endoscopic Third Ventriculostomy: The Lebanese Experience

Rahme

Rahme²,

Hourani³

et al. 2009

Pediatr Neurosurg

View full text Add to dashboard Cite

Background: Endoscopic third ventriculostomy (ETV) has gained wide popularity as a first-line treatment for obstructive hydrocephalus (OHC). We have been performing ETV since 1998. We report our experience with this technique in the management of OHC. Methods: Between 1998 and 2007, we performed 49 ETV procedures in 46 patients suffering from OHC. Medical records were retrospectively reviewed. Success was defined as shunt-free survival. Results: There were 29 males and 17 females with a mean age of 23 years (6 months–65 years). Aqueductal stenosis and tectal tumor were the most common etiologies (63%). Seven patients (15.6%) had early ETV failure. Of 38 patients with initial success and available follow-up, shunt independence was achieved in 29 patients (76.3%) after a mean follow-up of 37 months. Kaplan-Meier analysis yielded a 70% 5-year shunt-free survival rate. On multivariate analysis, no variables could predict early or late ETV failure. Transient complications occurred in 6 patients (13%), but there were no ETV-related deaths or permanent morbidity. Conclusion: ETV is a safe and effective treatment for OHC, resulting in a high rate of long-term shunt independence with a low risk of complications. ETV should be considered the treatment of choice for patients with OHC and its development as a substitute to shunt placement should be encouraged in neurosurgically developing countries.

show abstract

“…Infants presenting by hydrocephalus are not suitable applicants for ETV as they have not well-established absorptive surfaces in the subarachnoid spaces and have an open anterior fontanelle, with a lax skull (6,44). Yet, the ETV has been tried by numerous writers in infants with hydrocephalus, due to variable etiologies.…”

Section: Endoscopic Third Ventriculostomy Indicationsmentioning

confidence: 99%

Pediatric Endoscopic Third Ventriculostomy: A Narrative Review of Current Indications, Techniques and Complications

Haddadi¹

2016

J Pediatr Rev

View full text Add to dashboard Cite

Hydrocephalus is a disorder in which excess cerebrospinal fluid (CSF) collects in the brain. Possible managements for hydrocephalus contain CSF deviation through ventriculoperitoneal shunt assignment and endoscopic third ventriculostomy. An endoscopic third ventriculostomy has been in trend for the past two decades, as a tool in the field of the neurosurgery, for the management of hydrocephalus. Its utility has been confirmed consistently in congenital and acquired aqueductal stenosis, although the outcomes in communicating hydrocephalus and hydrocephalus secondary to other etiologies have not been impressive. It is a relatively harmless technique with the appropriate selection of patients with a low rate of enduring morbidity. Further studies in child should focus on the predictive factors that are specific to the older population. A combination of clinical, radiological, and intraoperative findings may be necessary to plan a clinical prediction rule suitable to this group of patients. The purpose of this review is to describe the current indications, management outcomes, techniques and complications of this method.

show abstract

Initial management of hydrocephalus associated with Chiari malformation Type I–syringomyelia complex via endoscopic third ventriculostomy: an outcome analysis

Cited by 98 publications

References 27 publications

Endoscopic third ventriculostomy in the management of hydrocephalus: Outcome analysis of 168 consecutive procedures

Endoscopic third ventriculostomy in the management of hydrocephalus: Outcome analysis of 168 consecutive procedures

Endoscopic Third Ventriculostomy: The Lebanese Experience

Pediatric Endoscopic Third Ventriculostomy: A Narrative Review of Current Indications, Techniques and Complications

Contact Info

Product

Resources

About